|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cadmium dust (as Cd) | CAS 7440-43-9 (metal) | ||
| Cd (metal) | RTECS EU9800000 (metal) | ||
|
Synonyms & Trade Names Cadmium metal: Cadmium Other synonyms vary depending upon the specific cadmium compound. |
DOT ID & Guide 2570 154 (compounds) |
||
|
Exposure Limits |
NIOSH REL*: Ca See Appendix A [*Note: The REL applies to all Cadmium compounds (as Cd).] | ||
| OSHA PEL*: [1910.1027] TWA 0.005 mg/m3 [*Note: The PEL applies to all Cadmium compounds (as Cd).] | |||
| IDLH Ca [9 mg/m3 (as Cd)] | Conversion | ||
|
Physical Description Metal: Silver-white, blue-tinged lustrous, odorless solid. |
|||
|
MW: 112.4 |
BP: 1409°F |
MLT: 610°F |
Sol: Insoluble |
|
VP: 0 mmHg (approx) |
IP: NA |
|
Sp.Gr: 8.65 (metal) |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Metal: Noncombustible Solid in bulk form, but will burn in powder form. | |||
|
Incompatibilities & Reactivities Strong oxidizers; elemental sulfur, selenium & tellurium |
|||
|
Measurement Methods NIOSH 7048; OSHA ID121, ID125G, ID189, ID206 |
|
Personal Protection & Sanitation Skin: No recommendation Eyes: No recommendation Wash skin: Daily Remove: No recommendation Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, ingestion | |
| Symptoms Pulmonary edema, dyspnea (breathing difficulty), cough, chest tightness, substernal (occurring beneath the sternum) pain; headache; chills, muscle aches; nausea, vomiting, diarrhea; anosmia (loss of the sense of smell), emphysema, proteinuria, mild anemia; [potential occupational carcinogen] | |
|
Target Organs
respiratory system, kidneys, prostate, blood Cancer Site [prostatic & lung cancer] |
|
| See also: INTRODUCTION |